HomeNDC LookupRxCUI directory › RxCUI 2169359

Trastuzumab-pkrb 150 MG Injection — RxCUI 2169359

RxNorm drug concept · Semantic clinical drug
RxCUI 2169359 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2169359
Official nameTrastuzumab-pkrb 150 MG Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped2
Package NDCs mapped2
Reported Medicaid activity (SDUD)119 prescriptions · 4 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Trastuzumab Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Trastuzumab is used for more than just breast cancer. It treats HER2-positive breast cancer — both early-stage (after surgery) and metastatic (spread) breast cancer. It's also appr...
  • What exactly is trastuzumab used for — is it just for breast cancer?
  • No, trastuzumab is not a pill. It's given as an IV infusion — a drip into a vein — at your cancer center or infusion clinic. Your very first infusion is given slowly over 90 minute...
  • How will I receive this medication? Do I take it as a pill?
📖 Read our full Trastuzumab Injection guide →

🕸️ Concept Web — How Trastuzumab-pkrb 150 MG Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Trastuzumab-pkrb 150 MG Injection RxCUI 2169359

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Trastuzumab 224905
    • Trastuzumab-pkrb 2107051
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Herzuma 2107054
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Trastuzumab Injection 1922508
    • Trastuzumab-pkrb Injection 2649142
    • Trastuzumab Injectable Product 1162762
    • Trastuzumab-pkrb Injectable Product 2661351
    • Trastuzumab Injection [Herzuma] 2169361
    • Trastuzumab-pkrb Injection [Herzuma] 2657916
    • Herzuma Injectable Product 2107057
    • Injection 1649574
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Trastuzumab-pkrb 150 MG SCDC · 2169358
  • Trastuzumab Injection SCDF · 1922508
  • Trastuzumab-pkrb Injection SCDFP · 2649142
  • Trastuzumab Injectable Product SCDG · 1162762
  • Trastuzumab-pkrb Injectable Product SCDGP · 2661351

Brand-Name Concepts

  • Trastuzumab-pkrb 150 MG Injection [Herzuma] SBD · 2169362
  • Trastuzumab-pkrb 150 MG [Herzuma] SBDC · 2169360
  • Trastuzumab Injection [Herzuma] SBDF · 2169361
  • Trastuzumab-pkrb Injection [Herzuma] SBDFP · 2657916
  • Herzuma Injectable Product SBDG · 2107057
  • Herzuma BN · 2107054

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 2169359 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
63459-0303-43 1 VIAL, SINGLE-DOSE in 1 CARTON (63459-303-43) / 20 mL in 1... HERZUMA Cephalon, Inc. 2020-03-16
63459-0305-47 1 KIT in 1 CARTON (63459-305-47) * 50 mL in 1 VIAL, MULTI-... HERZUMA Cephalon, Inc. 2020-03-16
Observed labelers: Cephalon, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
Q5113 Inj herzuma 10 mg 2 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.